Funded equally by LUNGevity Foundation and the American Thoracic Society
Charles A. Powell, MD
Columbia University
New York
Dr. Powell is identifying and characterizing molecular changes that are important in lung adenocarcinoma differentiation (changes in cancer cell shape and size) and invasiveness (ability to spread to other parts of the body). His long-term goal is to use these biomarkers to facilitate early diagnosis, refine prognostic assessment, and develop new therapeutic targets for lung cancer treatment and prevention.